BioNTech is a biotechnology company based in Germany, primarily known for its development of mRNA-based therapeutics and vaccines. It gained global prominence for its role in the development of one of the first COVID-19 vaccines, in collaboration with Pfizer. Founded in 2008, BioNTech focuses on the research and development of personalized cancer therapies and other infectious disease treatments. The company’s innovative approach utilizes the body’s immune system to fight diseases, leveraging mRNA technology to instruct cells to produce proteins that can provoke an immune response. This method represents a significant advancement in vaccine technology and holds promise for future therapeutic applications.
BioNTech doživi ostri padec prihodkov in dobičkov, ko povpraševanje po COVID-19 cepivih upada. Kljub finančnim težavam BioNTech presega pričakovanja trga v četrtletju. Preusmeritev na terapije proti raku, temelječe na mRNA,…